Back Page - Pharmaceutical Executive


Back Page
A pharma miscellany.

Who Lost Syria?

January 1, 2013

Thankfully, the civil war is not a public relations issue for Big Pharma, but the long-term business implications for the Middle East region are cagey.

Top Medical Innovations for 2013

December 1, 2012

Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.

Prix Galien: Night at the Museum

November 1, 2012

Prix Galien celebrates a new round of next generation drug technologies.

The Drug Vote 2012

October 1, 2012

A comparative effectiveness study on the two presidential candidates.

The Power of Patient Feedback

September 1, 2012

Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. Patient voices are increasing in volume, along with their roles in treatment decisions.

Brand Building—Not!

August 1, 2012

As a drug company promoting a drug free Olympiad, GSK wins our gold hands down for finally putting the industry's best face forward on the last frontier of advertising—the TV sets of Europe.

John Lechleiter on PhRMA and Innovation

July 1, 2012

Eli Lilly CEO John Lechleiter on his agenda as incoming chairman of PhRMA, US healthcare reform, the euro crisis, and the small problem, of innovation.

Disruption in the C-Suite

June 1, 2012

Clayton Christensen, author of "The Innovator's Dilemma", offers to collaborate with pharma CEOs on solutions to the strategic impasse around flagging drug productivity.

Comparing Apples to Broccoli

May 1, 2012

In late March, the Supreme Court debated the merits—or lack thereof—of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?


Click here